Eloxx Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Arlington, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Eloxx Pharmaceuticals, Inc. has filed 1,349 SEC EDGAR filings since 27 Mar 1997

SEC filing history

Showing 76-100 of 916 matching filings.

Per page
25
Current page
4
424B5 File 333-258994

424B5

Filing date
20 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258994

424B5

Filing date
11 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258994

424B5

Filing date
24 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-31326

FORM DEFA14A

Filing date
28 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-31326

DEF 14A

Filing date
28 Apr 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-31326

CT ORDER filing

Filing date
24 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-271035

FORM S-8

Filing date
31 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .